Search clinical trials for: carbohydrate periodisation
Total 1757 results
-
JCR Pharmaceuticals Co., Ltd.Active, not recruitingMucopolysaccharidosis IIJapan
-
Sun JiaCompleted
-
Massachusetts General HospitalActive, not recruitingCrohn's DiseaseUnited States
-
Mayo ClinicNovo Nordisk A/SActive, not recruiting
-
PTC TherapeuticsCompletedMitochondrial Diseases | Drug Resistant Epilepsy | Leigh Disease | Leigh Syndrome | Mitochondrial Encephalopathy (MELAS) | Pontocerebellar Hypoplasia Type 6 (PCH6) | Alpers Disease | Alpers SyndromeUnited States, Spain, United Kingdom, Canada, France, Italy, Poland, Sweden, Japan
-
Ausnutria Hyproca B.V.HM hospitalesCompleted
-
Genzyme, a Sanofi CompanyActive, not recruiting
-
Cedars-Sinai Medical CenterNovo Nordisk A/S; The Cure Parkinson's TrustCompleted
-
Indiana UniversityCompletedLactose IntoleranceUnited States
-
BioMarin PharmaceuticalICON plcCompletedMucopolysaccharidosis IV Type A | Morquio A Syndrome | MPS IVAUnited States, United Kingdom, Australia, Taiwan, Belgium, Malaysia, Austria, Canada, Portugal, France, Ireland, Czechia, Denmark, Italy, Netherlands, Poland, Puerto Rico
-
Children's Hospital Los AngelesCompletedObesity, ChildhoodUnited States
-
University of Alabama at BirminghamMayo Clinic; National Institute of Diabetes and Digestive and Kidney Diseases...CompletedDiabetes Mellitus, Type 2 | Diabetes MellitusUnited States
-
Genzyme, a Sanofi CompanyCompletedGlycogen Storage Disease Type II Pompe DiseaseUnited States, Belgium, Denmark, France, Germany, Netherlands, United Kingdom
-
Helsinki University Central HospitalUniversity of Helsinki; Aalto University; Finnish Institute for Health and Welfare and other collaboratorsActive, not recruitingBirth Weight | Body Composition | Diabetes, Gestational | Dietary Modification | Glucose Intolerance During PregnancyFinland
-
Anglia Ruskin UniversityUniversity of ExeterCompletedMuscle Soreness | Protein-energy; ImbalanceUnited Kingdom
-
Rigshospitalet, DenmarkCompletedGlycogen Storage Disease Type IIIDenmark
-
Rigshospitalet, DenmarkUltragenyx Pharmaceutical IncCompletedTarui Disease | Debrancher Deficiency | GYG1 DEFICIENCYDenmark
-
Lundquist Institute for Biomedical Innovation at...Swedish Orphan Biovitrum; Cure Sanfilippo FoundationCompleted
-
Federico II UniversityCompleted
-
Northwell HealthNational Institutes of Health (NIH)Completed
-
Pennington Biomedical Research CenterWeight Watchers InternationalCompleted
-
VA Office of Research and DevelopmentHunter Holmes McGuire VA Medical CenterCompleted
-
Charles University, Czech RepublicGeneral University Hospital, PragueCompletedDiabetes Mellitus, Type 1Czechia
-
Genzyme, a Sanofi CompanyBioMarin/Genzyme LLCTerminatedMucopolysaccharidosis I | Hurler's Syndrome | Hurler-Scheie Syndrome | ScheieItaly
-
Alnylam PharmaceuticalsCompletedPrimary Hyperoxaluria Type 1 (PH1)United States, France, United Kingdom, Switzerland, Netherlands, Israel, Germany, United Arab Emirates
-
Alnylam PharmaceuticalsApproved for marketingPrimary HyperoxaluriaBelgium
-
Vitaflo International, LtdUniversity College London Hospitals; University Medical Center Groningen; University... and other collaboratorsCompletedGlycogen Storage DiseaseUnited States, United Kingdom, France, Netherlands
-
University of CopenhagenDeakin UniversityCompleted
-
Yale UniversityNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)CompletedType 1 DiabetesUnited States
-
SanofiCompletedPompe Disease | Mucopolysaccharidosis Type I (MPS I)Italy
-
University of ManchesterUniversity College, London; Manchester University NHS Foundation Trust; Orchard... and other collaboratorsActive, not recruitingMucopolysaccharidosis Type IIIAUnited Kingdom
-
Muğla Sıtkı Koçman UniversityCompletedColorectal Cancer | Life Quality | Glucometabolic Response | Subjective GoodnessTurkey
-
Central Hospital, Nancy, FranceCompleted
-
McGill UniversityCanadian Institutes of Health Research (CIHR)CompletedMuscle Atrophy | Cognitive Function | Muscle Protein Synthesis | Insulin Sensitivity | Muscle Strength | Functional Capacity | Physical Inactivity | Mitochondrial FunctionCanada
-
Virginia Polytechnic Institute and State UniversityCompletedCardiovascular Risk FactorUnited States
-
University of RochesterActive, not recruitingHypertension | Hyperlipidemias | Heart Disease, IschemicUnited States
-
Rocket Pharmaceuticals Inc.Active, not recruiting
-
Cambridge University Hospitals NHS Foundation TrustUniversity of CambridgeTerminatedCardiovascular DiseasesUnited Kingdom
-
Florida State UniversityMilk Specialties GlobalEnrolling by invitation
-
Mayo ClinicChildren's Hospital of Philadelphia; Seattle Children's HospitalTerminated
-
Maastricht University Medical CenterPfizerCompleted
-
Hvidovre University HospitalUniversity of Copenhagen; Danish Research Centre for Magnetic ResonanceCompletedDiabetes | Metabolic Syndrome | NAFLD | Overweight and ObesityDenmark
-
Jens Rikardt AndersenCompleted
-
Dicerna Pharmaceuticals, Inc., a Novo Nordisk companyEnrolling by invitationKidney Diseases | Urologic Diseases | Genetic Disease | Primary Hyperoxaluria Type 1 (PH1) | Primary Hyperoxaluria Type 2 (PH2) | Primary Hyperoxaluria Type 3 (PH3)United States, France, Germany, Japan, Lebanon, Spain, United Kingdom, Australia, Canada, Italy, Netherlands, Norway, Turkey
-
Dr Rabia ArshadCompletedAntipsychotics and Neuroleptics ToxicityPakistan
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2Germany
-
Bispebjerg HospitalUniversity of Copenhagen; University Hospital Bispebjerg and FrederiksbergActive, not recruiting
-
SanofiCompletedOsteochondrodysplasiaUnited States